03.26.25 -- STREAM Edition: Improve The Patient Experience

Discover the inspiring journey of one man who battled diabetes and experienced a transformative shift in his life through a patient-focused clinical trial at the Elligo Clinical Research Center.

Harold Glass’ research highlighted subgroup differences among investigators, showing that even low-volume, less-experienced PIs expected to continue trials, often in co-investigator roles. Ken Getz of Tufts Center for the Study of Drug Development recognizes that Glass’ findings shaped further studies on turnover rates.

Whether you're a sponsor, site, or technology vendor, now is the time to embrace One Home and join this industry-wide collaboration.

This presentation aims to equip sponsors, researchers, and stakeholders with the tools to enhance trial resilience and ensure continuity in today’s unpredictable global landscape.

This presentation guides viewers through essential questions and real-world scenarios, helping to craft a successful Regulatory CMC roadmap throughout the clinical development lifecycle.

Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.

Without teamwork, the best solutions still fall short. Unlock your clinical data's potential and transform chaos into clarity by starting with clear questions, adapting to insights, and fostering collaboration.

While early-phase trials often rely on less capable, cost-effective systems, the transition to more complex studies in later phases necessitates a more robust EDC system.

Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

In this discussion, our panel of experts will explore the critical role of concierge services in clinical trials, focusing on how these services address participant needs.